Literature DB >> 2447201

Western blot analysis of the antibody response of patients with AIDS and toxoplasma encephalitis: antigenic diversity among Toxoplasma strains.

L M Weiss1, S A Udem, H Tanowitz, M Wittner.   

Abstract

We used immunoblotting to ascertain if toxoplasma encephalitis in disease caused by the human immunodeficiency virus (HIV) could be diagnosed by the appearance of characteristic antibodies recognizing specific Toxoplasma antigens. The profile of antibodies to Toxoplasma was examined in human serum and cerebrospinal fluid from patients with chronic and acute toxoplasmosis with or without HIV infection. Many Toxoplasma antigens were recognized by all sera; the majority were presumably surface proteins, as determined by 125I labeling. All sera recognized antigens at 38, 35, 28, and 26 kilodaltons. No specific antibody or pattern of antibodies distinguished between groups of patients. A 120-kilodalton antigen recognized by sera from Atlanta was not, however, seen in most sera from New York. Study of the recognition of the antigens of different strains of Toxoplasma gondii (RH, C56, T100) by the same human sera demonstrated strain-specific antigenic differences. These strain variations may account for the antibody diversity among the patients studied.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2447201     DOI: 10.1093/infdis/157.1.7

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  17 in total

Review 1.  The development and biology of bradyzoites of Toxoplasma gondii.

Authors:  L M Weiss; K Kim
Journal:  Front Biosci       Date:  2000-04-01

2.  Cyclic nucleotide kinases and tachyzoite-bradyzoite transition in Toxoplasma gondii.

Authors:  Michael S Eaton; Louis M Weiss; Kami Kim
Journal:  Int J Parasitol       Date:  2005-09-22       Impact factor: 3.981

3.  A new perspective on and re-assessment of SAG2 locus as the tool for genetic analysis of Toxoplasma gondii isolates.

Authors:  A Fazaeli; A Ebrahimzadeh
Journal:  Parasitol Res       Date:  2007-02-13       Impact factor: 2.289

4.  Immunoblot profile as predictor of toxoplasmic encephalitis in patients infected with human immunodeficiency virus.

Authors:  C Leport; J Franck; G Chene; F Derouin; J L Ecobichon; S Pueyo; J M Miro; B J Luft; P Morlat; H Dumon
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

5.  Immune responses and resistance to Toxoplasma gondii in mice immunized with antigens of the parasite incorporated into immunostimulating complexes.

Authors:  A Lundén; K Lövgren; A Uggla; F G Araujo
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

6.  Sequential reactivity of serum against cyst antigens in Toxoplasma infection.

Authors:  G Woodison; A H Balfour; J E Smith
Journal:  J Clin Pathol       Date:  1993-06       Impact factor: 3.411

7.  Diagnosis and Treatment of Toxoplasmosis of the CNS in Patients with AIDS.

Authors:  C Katlama
Journal:  CNS Drugs       Date:  1996-05       Impact factor: 5.749

8.  Improved diagnosis of reactivated toxoplasmosis.

Authors:  D Ashburn; M M Davidson; A W Joss; T H Pennington; D O Ho-Yen
Journal:  Mol Pathol       Date:  1998-04

9.  Identification and characterisation of a regulatory region in the Toxoplasma gondii hsp70 genomic locus.

Authors:  Yan Fen Ma; YiWei Zhang; Kami Kim; Louis M Weiss
Journal:  Int J Parasitol       Date:  2004-03-09       Impact factor: 3.981

10.  Differentiation between mouse-virulent and -avirulent strains of Toxoplasma gondii by a monoclonal antibody recognizing a 27-kilodalton antigen.

Authors:  W Bohne; U Gross; J Heesemann
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.